Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-13 of 13 for your search:
Drug:
dactinomycin
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer
Phase:
Phase IV
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and under
Sponsor:
Other
Protocol IDs:
PPRU 10762
, NCT00491946
2.
Phase III Randomized Study of Standard Induction Chemotherapy Comprising Vincristine, Dactinomycin, Ifosfamide, and Etoposide Followed By Consolidation Chemotherapy Comprising Vincristine, Dactinomycin, and Ifosfamide Versus High-Dose Busulfan and Melphalan Followed By Autologous Peripheral Blood Stem Cell Support With or Without Radiotherapy and/or Surgery in Patients With Tumor of the Ewing's Family
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 50
Sponsor:
NCI, Other
Protocol IDs:
EURO-EWING-INTERGROUP-EE99
, EBMT-INTERGROUP-EE99, EORTC-62981, GPOH-AUSTRIA-INTERGROUP-EE99, GPOH-GERMANY-INTERGROUP-EE99, SFOP-INTERGROUP-EE99, SWS-SAKK-INTERGROUP-EE99, CCLG-INTERGROUP-EE99, COG-AEWS0331, NCT00020566, AEWS0331
3.
Phase III Partially Randomized Study of Neoadjuvant Chemotherapy Followed By Surgery and Adjuvant Chemotherapy in Children With Wilms' Tumor
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and under
Sponsor:
Other
Protocol IDs:
SIOP-WT-2001
, SFOP-SIOP-WT-2001, CCLG-SIOP-WT-2001, GPOH-GERMANY-SIOP-WT-2001, EU-20208, NCT00047138
4.
Phase III Study of Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiotherapy in Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 50
Sponsor:
NCI
Protocol IDs:
COG-ARST0331
, NCT00075582, ARST0331
5.
Phase III Study of Adjuvant Vincristine, Dactinomycin and Doxorubicin Hydrochloride With or Without Radiotherapy or Observation Only in Younger Patients Who are Undergoing Nephrectomy for Newly Diagnosed Stage I-III Favorable Histology Wilms' Tumor
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 30 at diagnosis
Sponsor:
NCI
Protocol IDs:
COG-AREN0532
, AREN0532, NCT00352534
6.
Phase III Randomized Study of Vincristine, Dactinomycin, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan Hydrochloride in Combination With Radiotherapy in Patients With Newly Diagnosed, Intermediate-Risk Rhabdomyosarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 50
Sponsor:
NCI
Protocol IDs:
COG-ARST0531
, NCT00354835, ARST0531
7.
Phase III Study of Combination Chemotherapy With or Without Radiotherapy in Patients With Newly Diagnosed Stage III or IV Favorable Histology Wilms' Tumor
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 30
Sponsor:
NCI
Protocol IDs:
COG-AREN0533
, AREN0533, NCT00379340
8.
Phase III Randomized Study of Ifosfamide, Vincristine, and Dactinomycin With or Without Doxorubicin in Pediatric Patients With Non-Metastatic Rhabdomyosarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 21
Sponsor:
Other
Protocol IDs:
CCLG-EPSSG-RMS-2005
, EU-20639, EUDRACT-2005-000217-35, UKCCSG-RMS-2005, NCT00379457
9.
Phase II Study of Chemotherapy Followed By Surgical Resection and Adjuvant Radiotherapy With or Without Autologous Stem Cell Rescue in Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Under 18
Sponsor:
Other
Protocol IDs:
CCLG-UKWR
, EU-20127, NCT00025103
10.
Phase II Study of Intensive Chemotherapy Comprising Vincristine, Dactinomycin, and Cyclophosphamide Followed By Vincristine and Dactinomycin in Patients With Lower-Risk Embryonal Rhabdomyosarcoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Under 18
Sponsor:
Other
Protocol IDs:
JRSG-UHA-PED03-02
, NCT00245089
11.
Phase II Study of a Shortened Treatment Schedule of Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiotherapy in Patients With Low-Risk Embryonal Rhabdomyosarcoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Under 18
Sponsor:
Other
Protocol IDs:
JRSG-UHA-PED03-01
, NCT00245141
12.
Phase II Study of Combination Chemotherapy, Radiotherapy, and/or Surgery in Patients With High-Risk Renal Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
30 and under
Sponsor:
NCI
Protocol IDs:
COG-AREN0321
, AREN0321, NCT00335556
13.
Study of the Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics of Dactinomycin and Vincristine in Pediatric Patients With Cancer
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Under 17
Sponsor:
NCI
Protocol IDs:
COG-ADVL06B1
, ADVL06B1, NCT00674193
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
